LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Collection Tubes Influence Targeted Metabolomics Studies

By LabMedica International staff writers
Posted on 08 Oct 2018
Print article
Image: The QTRAP 6500 Q-Trap mass spectrometer (MS) (Photo courtesy of Sciex).
Image: The QTRAP 6500 Q-Trap mass spectrometer (MS) (Photo courtesy of Sciex).
Plasma and serum are the most widely used matrices in clinical studies. However, some variability in absolute concentrations of metabolites are likely to be observed in these collection tubes matrices.

Selecting the correct matrix for biochemical analysis is of paramount importance in order to avoid improper diagnosis. Blood collection tubes are often an under-recognized variable in the pre-analytical phase of clinical studies, and it is thus important to evaluate the influences of these matrices during metabolomics analysis.

An international team of scientists working with the Institute for Biomedicine (Eurac Research, Bolzano, Italy) enrolled a total of 40 healthy independent individuals who were selected with age lower than 35 years and assigned to the “young” group. The other 40 healthy independent subjects were selected with age higher than 60 years and assigned to the “elderly” group. Blood was collected at the recruitment center after overnight fasting, and taken in the early morning within a short time interval.

Serum, EDTA and Citrate Vacuette vacutainer collection tubes were provided by Greiner Bio-One. For liquid chromatography mass spectrometry, targeted analysis was performed using the Biocrates AbsoluteIDQ p180 kit with an ultra-high-performance liquid chromatography (UHPLC) coupled to a Q-Trap mass spectrometer (MS).

The team analyzed 189 metabolites using the same protocol for quantitative targeted metabolomics. The concentration levels were higher in serum than citrate and EDTA, in particular for amino acids and biogenic amines. For amino acids, the average value of the relative difference was 7% higher in serum than EDTA and 6% higher in serum than citrate. For biogenic amines the average value of the relative difference was 11% higher in serum than EDTA and 15% higher in serum than citrate. The investigators also demonstrated that blank EDTA vacutainer tubes contain a significant amount of sarcosine. Finally, they compared the metabolome of young people against elderly subjects and found that the highest number of metabolites significantly changing with age was detected in serum.

The authors concluded that serum samples provide higher sensitivity for biomarker discovery studies. Due to the presence of spurious amount of sarcosine in vacutainer EDTA tubes, plasma EDTA is not suitable for studies requiring accurate quantification of sarcosine. The study was published online on August 13, 2018, in the journal Clinica Chimica Acta.

Related Links:
Institute for Biomedicine

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Multi-Function Pipetting Platform
apricot PP5
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.